These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9667731

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.
    Devereux TR, Foley JF, Maronpot RR, Kari F, Anderson MW.
    Carcinogenesis; 1993 May; 14(5):795-801. PubMed ID: 8504471
    [Abstract] [Full Text] [Related]

  • 27. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas.
    Dai Y, Morishita Y, Mase K, Sato N, Akaogi E, Mitsui T, Noguchi M.
    Cancer; 2000 Aug 25; 90(4):258-63. PubMed ID: 10966568
    [Abstract] [Full Text] [Related]

  • 28. Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
    Gallinger S, Vivona AA, Odze RD, Mitri A, O'Beirne CP, Berk TC, Bapat BV.
    Oncogene; 1995 May 04; 10(9):1875-8. PubMed ID: 7753564
    [Abstract] [Full Text] [Related]

  • 29. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA, Williamson M.
    Cancer Res; 1993 Jan 01; 53(1):133-9. PubMed ID: 8093230
    [Abstract] [Full Text] [Related]

  • 30. Detection of K-ras mutations in lung carcinomas: relationship to prognosis.
    Keohavong P, DeMichele MA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM.
    Clin Cancer Res; 1996 Feb 01; 2(2):411-8. PubMed ID: 9816185
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.
    Graziano SL, Gamble GP, Newman NB, Abbott LZ, Rooney M, Mookherjee S, Lamb ML, Kohman LJ, Poiesz BJ.
    J Clin Oncol; 1999 Feb 01; 17(2):668-75. PubMed ID: 10080613
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of activating ras mutations in morphologically characterized thyroid nodules.
    Ezzat S, Zheng L, Kolenda J, Safarian A, Freeman JL, Asa SL.
    Thyroid; 1996 Oct 01; 6(5):409-16. PubMed ID: 8936664
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. K-ras mutations in mouse lung tumors of extreme age: independent of paternal preconceptional exposure to chromium(III) but significantly more frequent in carcinomas than adenomas.
    McKenna IM, Ramakrishna G, Diwan BA, Shiao YH, Kasprzak KS, Powell DA, Anderson LM.
    Mutat Res; 2001 Jan 25; 490(1):57-65. PubMed ID: 11152972
    [Abstract] [Full Text] [Related]

  • 39. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 40. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.
    Mills NE, Fishman CL, Scholes J, Anderson SE, Rom WN, Jacobson DR.
    J Natl Cancer Inst; 1995 Jul 19; 87(14):1056-60. PubMed ID: 7616596
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.